A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group.

A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group. Crit Care Med. 1995 Jun; 23(6):994-1006.

View in: PubMed

subject areas

Antibodies, Monoclonal
Double-Blind Method
Female
Gram-Negative Bacterial Infections
Humans
Immunoglobulin M
Immunoglobulins
Male
Middle Aged
Multiple Organ Failure
Prospective Studies
Sepsis
Survival Analysis
Treatment Outcome

authors with profiles

Robert Balk